Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

TB-500 Post-Surgery Research — Comparison

Primary Mechanism Actin sequestration → cellular migration; MMP upregulation → ECM remodeling Angiogenesis via VEGF; nitric oxide modulation; gut-brain axis signaling Endogenous healing cascade without exogenous modulation TB-500 targets structural tissue migr

This comparison does not assign a generated winner or score.

  • Primary Mechanism
  • Actin sequestration → cellular migration; MMP upregulation → ECM remodeling
  • Angiogenesis via VEGF; nitric oxide modulation; gut-brain axis signaling
  • Endogenous healing cascade without exogenous modulation
  • TB-500 targets structural tissue migration; BPC-157 emphasizes vascular support. Mechanisms complement rather than overlap. Some researchers combine both.
  • Optimal Timing Window
  • Days 0–14 post-op (acute inflammatory phase)
  • Days 3–21 post-op (proliferative phase)
  • N/A
  • TB-500 front-loaded early captures the inflammatory-to-proliferative transition; BPC-157 sustains angiogenesis during tissue remodeling. Delayed administration reduces efficacy for both.
  • Evidence Base
  • 15+ peer-reviewed studies in orthopedic/cardiac models; NIH-funded tendon repair trials
  • 40+ rodent studies; limited human data; primarily gastric ulcer and ligament models
  • Extensive clinical data across all surgical specialties
  • BPC-157 has higher publication volume but weaker translational evidence; TB-500 has fewer studies but stronger mechanistic validation in human-relevant tissue types. Neither has FDA approval.
  • Dosing Precision Required
  • High. Front-loading during acute phase critical; improper timing reduces outcomes significantly
  • Moderate. Broader therapeutic window during proliferative phase
  • TB-500 demands stricter adherence to post-op timelines; BPC-157 more forgiving of delayed starts but less impactful on early cellular migration events.
  • Cost (4-Week Protocol)
  • $180–$320 for research-grade TB-500 at 5mg twice weekly × 2 weeks, then 2.5mg weekly × 4 weeks
  • $120–$200 for research-grade BPC-157 at 500mcg daily × 28 days
  • $0
  • TB-500 costs 50–60% more due to longer peptide sequence (43 amino acids vs 15 for BPC-157). Synthesis complexity drives price.
More references

Related material